|
Randomized controlled trials have shown
that mammographic screening reduces breast
cancers death, but it remains to be established
how to use screening to its maximal life-sparing
effect, particularly as regards the optimal
screening interval. Over the last several
years, my colleagues and I have assembled
data on the rates of breast cancer growth
and spread as well as on the limits of
mammographic detectability. We have also
developed of a computer simulation model
of breast cancer growth and spread, which
can calculate such things as the relationship
between the screening interval and the
fraction of women likely to die from breast
cancer. The results of these studies have
indicated that great reductions in breast
cancer death should be achievable by prompt
compliance with the annual screening recommendation,
and that even greater numbers of lives
might be saved by screening more frequently
than once a year. However, from the analysis
of the patterns of utilization among women
who use screening, it is clear that full
utilization of screening in very incomplete,
and this provides a barrier to the realization
of the full life-sparing potential of
screening mammography.
Ongoing research concerns the collection
of data for improved estimates of breast
cancer growth, spread, and operational
detectability, as well as data on the
operational aspects of breast cancer screening.
Particular interest concerns what determines
whether a woman will return (or fail to
return) for screening, as well as development
of tools, such as computer driven automated
telephony reminder systems, which can
improve the utilization of screening.
If you would like additional information
on this research project, please contact:
James S. Michaelson, PhD at 617-724-3868
James S. Michaelson, PhD
Assistant Professor of Pathology
Division of Surgical Oncology, Massachusetts
General Hospital |